Erlotinib ve 4. linii léčby nemalobuněčného plicního karcinomu.

Authors

VENCLÍČEK Ondřej TOMÍŠKOVÁ Marcela SKŘIČKOVÁ Jana

Year of publication 2013
Type Article in Periodical
Magazine / Source Farmakoterapie
Citation

You are running an old browser version. We recommend updating your browser to its latest version.

More info